What the Elvie-Willow Deal Really Means for the Future of Femtech
A candid look at the risks, realities, and road ahead for women’s health innovation.
This isn’t our usual newsletter. Today’s issue breaks down one of the most significant shakeups in femtech to date: Willow’s acquisition of Elvie, a distressed sale that reveals deeper fault lines across the women’s health innovation landscape.
FemmeHealth Ventures Alliance is your trusted source for investor-grade insight into women’s health technology.…
Keep reading with a 7-day free trial
Subscribe to The Billion Dollar Blindspot to keep reading this post and get 7 days of free access to the full post archives.